Anthony Ofori | Medical Graduate in General Medicine | Founder, WellNest Central
Last updated: October 29, 2026
General health information; this article does not replace individualized medical assessment or treatment.
Respiratory syncytial virus, or RSV, often causes cold-like symptoms, but it can be serious in older adults and people with certain medical conditions. U.S. vaccine guidance now includes adults ages 50–74 who have increased risk of severe illness, as well as all adults ages 75 and older.
Need personal guidance about your respiratory health?
Explore a one-on-one, medically informed consultation focused on your symptoms, wellness priorities, and individual concerns.
What RSV does in adults
RSV infects the respiratory tract and can cause runny nose, coughing, sneezing, congestion, fever, reduced appetite, and wheezing. Some adults experience only mild symptoms, while others develop lower respiratory tract infection. Symptoms overlap with influenza and COVID-19, making the exact virus difficult to identify from symptoms alone.
Who is at higher risk?
The risk of severe RSV increases with age and medical vulnerability. Chronic heart or lung disease, weakened immune function, frailty, and certain other conditions can increase risk. Adults in long-term care settings may face additional exposure and complication risks. Not everyone over age 50 needs the same level of intervention; risk assessment matters.
When symptoms become more serious
Worsening shortness of breath, difficulty getting enough oxygen, marked fatigue, or dehydration may indicate a complication. RSV can aggravate existing asthma, COPD, or heart failure. Older adults sometimes show atypical symptoms. Prompt assessment helps determine whether supportive care at home is sufficient or higher-level treatment is needed.
Current U.S. RSV vaccine recommendations
As of CDC guidance published February 2026, a single RSV vaccine dose is recommended for all adults age 75 and older and adults ages 50 through 74 who are at increased risk of severe RSV illness. The RSV vaccine is not currently an annual vaccine, and people who have already received a recommended dose should not repeat it at this time. Vaccine eligibility and individual medical factors should be reviewed with a qualified vaccinator.
When to get vaccinated
Eligible adults can receive an RSV vaccine at any time, with late summer or early fall often preferred in most of the continental United States. Vaccine supply and local seasonal patterns can affect scheduling. Three FDA-licensed RSV vaccines are available for eligible adults, and CDC does not express a preferred brand. A previous dose should be documented before another one is considered.
How RSV spreads
RSV spreads through respiratory particles and contact with contaminated hands or surfaces. Close contact with someone ill can increase exposure. Frequent handwashing, improving indoor air, and avoiding close contact while sick are practical prevention steps. People may be contagious before symptoms fully develop, so precautions are especially useful around older and medically vulnerable adults.
How RSV is diagnosed and treated
Testing may be useful when results would affect clinical decisions or infection-control measures. Most mild cases are managed with supportive care, including fluids and symptom relief. Antibiotics do not treat RSV itself. Some patients require oxygen or hospitalization for complications. New respiratory symptoms in high-risk adults deserve timely attention.
RSV, flu, and COVID-19
These respiratory viruses share symptoms but differ in available treatments, vaccines, and complications. Do not assume a negative home COVID-19 test automatically establishes RSV. Clinical assessment can help select testing and management in vulnerable people. Keep vaccination and other preventive measures up to date based on eligibility.
Practical questions to consider
Pay attention to when symptoms began, whether they are improving or getting worse, any underlying heart or lung disease, and exposure to high-risk family members. A brief record of fever, breathing symptoms, and medications may make health discussions clearer. Take urgent warning signs seriously rather than relying on an online symptom checklist.
For related reading on another health topic, visit our WellNest Central health library. For current U.S. recommendations and further detail, see the relevant CDC guidance.
Frequently asked questions
Can healthy adults in their 50s get RSV?
Yes. Infection is possible at any age, although severe disease risk varies.
Do adults need an RSV vaccine every year?
No. Under the cited CDC guidance, the adult RSV vaccine is not currently annual.
Making RSV prevention practical for families
Adults may underestimate RSV because it is often discussed in connection with infants. However, aging and certain chronic diseases can reduce the body’s ability to tolerate a lower respiratory tract infection. In adults over 50 with increased risk, recognizing symptoms early and considering vaccination eligibility are particularly important. Severe disease is not inevitable, and many cases remain mild.
A person with RSV may develop worsening wheeze or breathlessness, especially if they already have asthma, COPD, or heart failure. New confusion, inability to maintain fluid intake, or significant functional decline in an older adult should also prompt attention. Care decisions are based on clinical severity rather than the virus name alone. Antibiotics are not routinely useful against a viral RSV infection.
RSV vaccination for adults under current CDC guidance is based on age and risk. People ages 50–74 qualify when they have increased risk for severe illness, while those ages 75 and older are recommended to receive a dose regardless of the listed additional risk factors. Because the adult vaccine is currently not an annual series, a prior dose should be discussed and documented before another is considered.
Family members can help by limiting close contact while sick, increasing indoor air exchange, cleaning hands, and paying attention to shared caregiving settings. Even apparently mild respiratory symptoms can matter for a medically vulnerable relative. Routine supportive care for mild illness includes rest and appropriate hydration, but signs of breathing difficulty require timely assessment.
Questions to ask about RSV risk
Risk factors for RSV complications extend beyond age alone. Adults with chronic heart disease, COPD, asthma, immune suppression, or frailty may be particularly vulnerable. Some underlying medical conditions are included in the CDC’s risk criteria for vaccination in adults ages 50–74. An individual’s eligibility should be checked against the latest guidance rather than assumed from age alone.
If you live with an older adult, encourage conversations about vaccination before respiratory virus season. The CDC’s adult RSV recommendation involves a single dose under current guidance, not a yearly booster. People who already received a vaccine should bring that record when discussing future immunizations. A clinician can also consider timing alongside other vaccinations.
Not every cough in winter is RSV. Influenza and COVID-19 may look similar, and testing can be important when it changes treatment, especially for high-risk patients. Seek prompt care for worsening respiratory symptoms, marked weakness, or problems maintaining hydration.
Key takeaways
Symptoms and contagiousness depend on the actual cause of illness and individual risk factors. Prioritize recovery, appropriate precautions, and timely clinical evaluation for worsening or serious symptoms.
Want to explore your personal health concerns? Book a personal consultation with WellNest Central.
